BioNexus Gene Lab Corp.
BGLC | NASDAQ
$1.46
-$0.04 (-2.67%)
At close: Sep 22, 2026, 4:00 PM ET
$1.45
-$0.01 (-0.68%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Company Profile
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Key Executives
| Name | Position |
|---|---|
| Su-Leng Tan | Chief Executive Officer, President, Secretary & Director |
| Set Fui Chong | Chief Financial Officer |
| Kwan Wah Chan | Marketing Manager |
| Too Kam Tham | Managing Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 31, 2026 | 3 | Filing |
| Jul 31, 2026 | 3 | Filing |
| Jul 31, 2026 | 3 | Filing |
| Jul 31, 2026 | 3 | Filing |
| Jul 31, 2026 | 3 | Filing |
| Jul 28, 2026 | 8-K | Current Report |
| Jun 05, 2026 | 8-K | Current Report |
| May 15, 2026 | 10-Q | Quarterly Report |
| Apr 14, 2026 | 10-K | Annual Report |
| Mar 31, 2026 | NT 10-K | Filing |
BioNexus Gene Lab Corp.
| Country | Malaysia |
| IPO Date | Jan 7, 2021 |
| Industry | Industrial - Distribution |
| Sector | Industrials |
| Employees | 19 |
| CEO | Su-Leng Tan |
Contact Details
Tower B, Vertical Business Suite Kuala Lumpur,
WP 59200 Malaysia
Stock Details
| Ticker Symbol | BGLC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001737523 |
| CUSIP Number | 090628306 |
| ISIN Number | US0906283066 |
| SIC Code | 8071 |
Add to Watchlist
Select watchlists to add or remove BGLC